Literature DB >> 20388541

Muscle degeneration in neuraminidase 1-deficient mice results from infiltration of the muscle fibers by expanded connective tissue.

Edmar Zanoteli1, Diantha van de Vlekkert, Erik J Bonten, Huimin Hu, Linda Mann, Elida M Gomero, A John Harris, Giulio Ghersi, Alessandra d'Azzo.   

Abstract

Neuraminidase 1 (NEU1) regulates the catabolism of sialoglycoconjugates in lysosomes. Congenital NEU1 deficiency in children is the basis of sialidosis, a severe neurosomatic disorder in which patients experience a broad spectrum of clinical manifestations varying in the age of onset and severity. Osteoskeletal deformities and muscle hypotonia have been described in patients with sialidosis. Here we present the first comprehensive analysis of the skeletal muscle pathology associated with loss of Neu1 function in mice. In this animal model, skeletal muscles showed an expansion of the epimysial and perimysial spaces, associated with proliferation of fibroblast-like cells and abnormal deposition of collagens. Muscle fibers located adjacent to the expanded connective tissue underwent extensive invagination of their sarcolemma, which resulted in the infiltration of the fibers by fibroblast-like cells and extracellular matrix, and in their progressive cytosolic fragmentation. Both the expanded connective tissue and the juxtaposed infiltrated muscle fibers were strongly positive for lysosomal markers and displayed increased proteolytic activity of lysosomal cathepsins and metalloproteinases. These combined features could lead to abnormal remodeling of the extracellular matrix that could be responsible for sarcolemmal invagination and progressive muscle fiber degeneration, ultimately resulting in an overt atrophic phenotype. This unique pattern of muscle damage, which has never been described in any myopathy, might explain the neuromuscular manifestations reported in patients with the type II severe form of sialidosis. More broadly, these findings point to a potential role of NEU1 in cell proliferation and extracellular matrix remodeling. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20388541      PMCID: PMC2906380          DOI: 10.1016/j.bbadis.2010.04.002

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  40 in total

1.  Angiotensin II, oxidative stress, and extracellular matrix degradation during transition to LV failure in rats with hypertension.

Authors:  Hiroyuki Takenaka; Yasuki Kihara; Yoshitaka Iwanaga; Yoko Onozawa; Shinya Toyokuni; Toru Kita
Journal:  J Mol Cell Cardiol       Date:  2006-09-18       Impact factor: 5.000

Review 2.  There's more to life than neurotransmission: the regulation of exocytosis by synaptotagmin VII.

Authors:  Norma W Andrews; Sabyasachi Chakrabarti
Journal:  Trends Cell Biol       Date:  2005-09-15       Impact factor: 20.808

Review 3.  Role of autophagy in the pathogenesis of Pompe disease.

Authors:  N Raben; A Roberts; P H Plotz
Journal:  Acta Myol       Date:  2007-07

Review 4.  Autophagic vacuolar myopathy.

Authors:  Ichizo Nishino
Journal:  Semin Pediatr Neurol       Date:  2006-06       Impact factor: 1.636

5.  Soluble betaglycan reduces renal damage progression in db/db mice.

Authors:  Patricia Juárez; M Magdalena Vilchis-Landeros; José Ponce-Coria; Valentín Mendoza; Rogelio Hernández-Pando; Norma A Bobadilla; Fernando López-Casillas
Journal:  Am J Physiol Renal Physiol       Date:  2006-09-05

6.  Autophagic vacuoles with sarcolemmal features delineate Danon disease and related myopathies.

Authors:  Kazuma Sugie; Satoru Noguchi; Yoshimichi Kozuka; Eri Arikawa-Hirasawa; Mikihito Tanaka; Chuanzhu Yan; Paul Saftig; Kurt von Figura; Michio Hirano; Satoshi Ueno; Ikuya Nonaka; Ichizo Nishino
Journal:  J Neuropathol Exp Neurol       Date:  2005-06       Impact factor: 3.685

7.  Lysosomal sialidase (neuraminidase-1) is targeted to the cell surface in a multiprotein complex that facilitates elastic fiber assembly.

Authors:  Aleksander Hinek; Alexey V Pshezhetsky; Mark von Itzstein; Barry Starcher
Journal:  J Biol Chem       Date:  2005-11-28       Impact factor: 5.157

8.  Neuraminidase 1 is a negative regulator of lysosomal exocytosis.

Authors:  Gouri Yogalingam; Erik J Bonten; Diantha van de Vlekkert; Huimin Hu; Simon Moshiach; Samuel A Connell; Alessandra d'Azzo
Journal:  Dev Cell       Date:  2008-07       Impact factor: 12.270

9.  Regulation of arterial lesions in mice depends on differential smooth muscle cell migration: a role for sphingosine-1-phosphate receptors.

Authors:  Shinya Inoue; Tatsu Nakazawa; Aesim Cho; Frank Dastvan; Frank Davastan; Dustin Shilling; Günter Daum; Michael Reidy
Journal:  J Vasc Surg       Date:  2007-10       Impact factor: 4.268

10.  Human sialidase as a cancer marker.

Authors:  Taeko Miyagi; Tadashi Wada; Kazunori Yamaguchi; Kazuhiro Shiozaki; Ikuro Sato; Yoichiro Kakugawa; Hideaki Yamanami; Tsuneaki Fujiya
Journal:  Proteomics       Date:  2008-08       Impact factor: 3.984

View more
  26 in total

1.  Neuraminidase-1 mediates skeletal muscle regeneration.

Authors:  Juliana de Carvalho Neves; Vanessa Rodrigues Rizzato; Alan Fappi; Mariana Miranda Garcia; Gerson Chadi; Diantha van de Vlekkert; Alessandra d'Azzo; Edmar Zanoteli
Journal:  Biochim Biophys Acta       Date:  2015-05-19

Review 2.  Lysosomal multienzyme complex: pros and cons of working together.

Authors:  Erik J Bonten; Ida Annunziata; Alessandra d'Azzo
Journal:  Cell Mol Life Sci       Date:  2013-12-15       Impact factor: 9.261

Review 3.  Where catabolism meets signalling: neuraminidase 1 as a modulator of cell receptors.

Authors:  Alexey V Pshezhetsky; Aleksander Hinek
Journal:  Glycoconj J       Date:  2011-09-20       Impact factor: 2.916

4.  Molecular mechanisms of pathogenesis in a glycosphingolipid and a glycoprotein storage disease.

Authors:  Alessandra d'Azzo; Erik Bonten
Journal:  Biochem Soc Trans       Date:  2010-12       Impact factor: 5.407

Review 5.  Lysosomal storage diseases.

Authors:  Frances M Platt; Alessandra d'Azzo; Beverly L Davidson; Elizabeth F Neufeld; Cynthia J Tifft
Journal:  Nat Rev Dis Primers       Date:  2018-10-01       Impact factor: 52.329

6.  Chaperone-mediated gene therapy with recombinant AAV-PPCA in a new mouse model of type I sialidosis.

Authors:  Erik J Bonten; Gouri Yogalingam; Huimin Hu; Elida Gomero; Diantha van de Vlekkert; Alessandra d'Azzo
Journal:  Biochim Biophys Acta       Date:  2013-06-12

7.  Analysis of Generalized Fibrosis in Mouse Tissue Sections with Masson's Trichrome Staining.

Authors:  Diantha Van De Vlekkert; Eda Machado; Alessandra d'Azzo
Journal:  Bio Protoc       Date:  2020-05-20

8.  Pathogenesis, Emerging therapeutic targets and Treatment in Sialidosis.

Authors:  Alessandra d'Azzo; Eda Machado; Ida Annunziata
Journal:  Expert Opin Orphan Drugs       Date:  2015-04-13       Impact factor: 0.694

9.  Neu1 deficiency induces abnormal emotional behavior in zebrafish.

Authors:  Asami Ikeda; Mayu Komamizu; Akito Hayashi; Chiharu Yamasaki; Keiji Okada; Momoko Kawabe; Masaharu Komatsu; Kazuhiro Shiozaki
Journal:  Sci Rep       Date:  2021-06-29       Impact factor: 4.379

10.  Autophagy is affected in patients with hypokalemic periodic paralysis: an involvement in vacuolar myopathy?

Authors:  Thomas O Krag; Sonja Holm-Yildiz; Nanna Witting; John Vissing
Journal:  Acta Neuropathol Commun       Date:  2021-06-13       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.